The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Understanding Your LabsUnderstanding Your Labs
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

macrophage-activating factor

Jan 18, 2009

I hope you reply to my question.. please.

Dear doc It is on-line on the web site of The Journal of medical virology and Clinical immunology an abstract of Yamamoto's research where he claims HIV ERADICATION in humans. Abstracts are reviewed by the society who is holding the meeting, in this case, the Federation of Clinical Immunology Society. Abstracts are NOT peer reviewed and are published as an abstract of what the authors will present at the meeting/magazine.

What do you think?

Why so small or any interest in Yamamoto results ?

I know that macrophage-activating factor can not be patend and will not be developed by any drug company.

What will happen in the near future if the bigpharma are not interested?

Simple will vanish that opportunity?

Response from Dr. Holodniy

Not enough data was presented to determine if a "cure" was documented. Changes in viral load and/or CD4 count are not sufficient.

Early treatment
Big (400) drop in CD4 not %

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint